Ceribell, Stock Current Liabilities

CBLL Stock   29.61  0.02  0.07%   
CeriBell, fundamentals help investors to digest information that contributes to CeriBell,'s financial success or failures. It also enables traders to predict the movement of CeriBell, Stock. The fundamental analysis module provides a way to measure CeriBell,'s intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to CeriBell, stock.
The value of Total Current Liabilities is estimated to slide to about 17.3 M. The value of Non Current Liabilities Total is expected to slide to about 125 M.
  
This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

CeriBell, Company Current Liabilities Analysis

CeriBell,'s Current Liabilities is the company's short term debt. This usually includes obligations that are due within the next 12 months or within one fiscal year. Current liabilities are very important in analyzing a company's financial health as it requires the company to convert some of its current assets into cash.

Current Liabilities

 = 

Payables

+

Accrued Debt

More About Current Liabilities | All Equity Analysis

CeriBell, Current Liabilities Driver Correlations

Understanding the fundamental principles of building solid financial models for CeriBell, is extremely important. It helps to project a fair market value of CeriBell, Stock properly, considering its historical fundamentals such as Current Liabilities. Since CeriBell,'s main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of CeriBell,'s historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of CeriBell,'s interrelated accounts and indicators.
Current liabilities appear on the company's balance sheet and include all short term debt accounts, accounts and notes payable, accrued liabilities as well as current payments due on the long-term loans. One of the most useful applications of Current Liabilities is the current ratio which is defined as current assets divided by its current liabilities. High current ratios mean that current assets are more than sufficient to pay off current liabilities.
Competition

In accordance with the recently published financial statements, CeriBell, has a Current Liabilities of 0.0. This is 100.0% lower than that of the Healthcare sector and 100.0% lower than that of the Medical Devices industry. The current liabilities for all United States stocks is 100.0% higher than that of the company.

CeriBell, Current Liabilities Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses CeriBell,'s direct or indirect competition against its Current Liabilities to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of CeriBell, could also be used in its relative valuation, which is a method of valuing CeriBell, by comparing valuation metrics of similar companies.
CeriBell, is currently under evaluation in current liabilities category among its peers.

CeriBell, Fundamentals

About CeriBell, Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze CeriBell,'s financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of CeriBell, using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of CeriBell, based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether CeriBell, is a strong investment it is important to analyze CeriBell,'s competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact CeriBell,'s future performance. For an informed investment choice regarding CeriBell, Stock, refer to the following important reports:
Check out CeriBell, Piotroski F Score and CeriBell, Altman Z Score analysis.
For more information on how to buy CeriBell, Stock please use our How to buy in CeriBell, Stock guide.
You can also try the AI Portfolio Architect module to use AI to generate optimal portfolios and find profitable investment opportunities.
Is Medical Equipment space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of CeriBell,. If investors know CeriBell, will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about CeriBell, listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of CeriBell, is measured differently than its book value, which is the value of CeriBell, that is recorded on the company's balance sheet. Investors also form their own opinion of CeriBell,'s value that differs from its market value or its book value, called intrinsic value, which is CeriBell,'s true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because CeriBell,'s market value can be influenced by many factors that don't directly affect CeriBell,'s underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between CeriBell,'s value and its price as these two are different measures arrived at by different means. Investors typically determine if CeriBell, is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, CeriBell,'s price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.